Given its multifactorial pathogenesis involving chronic inflammation and malnutrition, integrated biomarkers for early risk assessment are needed.<h4>Methods</h4>This two-cohort study investigated the clinical utility of the neutrophil percentage-to-albumin ratio (NPAR) for sarcopenia risk stratification. The gene discussed is ALB; the disease is sarcopenia.